The increase in orexin in the cerebrospinal fluid (CSF) of AD patients leads to an increase in wakefulness during the night, prolonged sleep latency (LPS), decreased sleep efficiency (SE) and rapid eye movement sleep (REM) (19). Here, HCRT is linked to Alzheimer disease.